WAVE LIFE SCIENCES LTD (WVE) Fundamental Analysis & Valuation

NASDAQ:WVE • SG9999014716

Current stock price

7.32 USD
-0.27 (-3.56%)
At close:
7.57 USD
+0.25 (+3.42%)
Pre-Market:

This WVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. WVE Profitability Analysis

1.1 Basic Checks

  • In the past year WVE has reported negative net income.
  • In the past year WVE has reported a negative cash flow from operations.
  • In the past 5 years WVE always reported negative net income.
  • WVE had a negative operating cash flow in each of the past 5 years.
WVE Yearly Net Income VS EBIT VS OCF VS FCFWVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • WVE has a Return On Assets (-32.01%) which is comparable to the rest of the industry.
  • The Return On Equity of WVE (-38.84%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -32.01%
ROE -38.84%
ROIC N/A
ROA(3y)-26.82%
ROA(5y)-50.01%
ROE(3y)-68.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WVE Yearly ROA, ROE, ROICWVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for WVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WVE Yearly Profit, Operating, Gross MarginsWVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. WVE Health Analysis

2.1 Basic Checks

  • WVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WVE has been increased compared to 1 year ago.
  • Compared to 5 years ago, WVE has more shares outstanding
  • WVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WVE Yearly Shares OutstandingWVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
WVE Yearly Total Debt VS Total AssetsWVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • WVE has an Altman-Z score of 4.39. This indicates that WVE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.39, WVE is in the better half of the industry, outperforming 70.68% of the companies in the same industry.
  • There is no outstanding debt for WVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.39
ROIC/WACCN/A
WACC9.34%
WVE Yearly LT Debt VS Equity VS FCFWVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 6.47 indicates that WVE has no problem at all paying its short term obligations.
  • WVE's Current ratio of 6.47 is fine compared to the rest of the industry. WVE outperforms 71.20% of its industry peers.
  • WVE has a Quick Ratio of 6.47. This indicates that WVE is financially healthy and has no problem in meeting its short term obligations.
  • WVE has a Quick ratio of 6.47. This is in the better half of the industry: WVE outperforms 71.73% of its industry peers.
Industry RankSector Rank
Current Ratio 6.47
Quick Ratio 6.47
WVE Yearly Current Assets VS Current LiabilitesWVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. WVE Growth Analysis

3.1 Past

  • The earnings per share for WVE have decreased strongly by -54.43% in the last year.
  • Looking at the last year, WVE shows a very negative growth in Revenue. The Revenue has decreased by -60.55% in the last year.
  • The Revenue has been growing by 16.30% on average over the past years. This is quite good.
EPS 1Y (TTM)-54.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.47%
Revenue 1Y (TTM)-60.55%
Revenue growth 3Y127.06%
Revenue growth 5Y16.3%
Sales Q2Q%-79.41%

3.2 Future

  • WVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.26% yearly.
  • Based on estimates for the next years, WVE will show a very strong growth in Revenue. The Revenue will grow by 71.03% on average per year.
EPS Next Y-13.9%
EPS Next 2Y-6.23%
EPS Next 3Y-0.57%
EPS Next 5Y25.26%
Revenue Next Year-0.18%
Revenue Next 2Y36.14%
Revenue Next 3Y59.21%
Revenue Next 5Y71.03%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WVE Yearly Revenue VS EstimatesWVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
WVE Yearly EPS VS EstimatesWVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. WVE Valuation Analysis

4.1 Price/Earnings Ratio

  • WVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WVE Price Earnings VS Forward Price EarningsWVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WVE Per share dataWVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.23%
EPS Next 3Y-0.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WVE Dividend Analysis

5.1 Amount

  • WVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WVE Fundamentals: All Metrics, Ratios and Statistics

WAVE LIFE SCIENCES LTD

NASDAQ:WVE (4/16/2026, 8:06:30 PM)

Premarket: 7.57 +0.25 (+3.42%)

7.32

-0.27 (-3.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners92.99%
Inst Owner Change-0.02%
Ins Owners0.49%
Ins Owner Change7.24%
Market Cap1.38B
Revenue(TTM)42.73M
Net Income(TTM)-204.38M
Analysts85
Price Target28.29 (286.48%)
Short Float %8.18%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.09%
Min EPS beat(2)-9.98%
Max EPS beat(2)-6.2%
EPS beat(4)0
Avg EPS beat(4)-7.97%
Min EPS beat(4)-10.05%
Max EPS beat(4)-5.63%
EPS beat(8)1
Avg EPS beat(8)8.2%
EPS beat(12)4
Avg EPS beat(12)-24.1%
EPS beat(16)5
Avg EPS beat(16)-19.36%
Revenue beat(2)1
Avg Revenue beat(2)-13.78%
Min Revenue beat(2)-32.32%
Max Revenue beat(2)4.76%
Revenue beat(4)1
Avg Revenue beat(4)-17.69%
Min Revenue beat(4)-32.32%
Max Revenue beat(4)4.76%
Revenue beat(8)2
Avg Revenue beat(8)-10.7%
Revenue beat(12)5
Avg Revenue beat(12)15.21%
Revenue beat(16)5
Avg Revenue beat(16)-8.86%
PT rev (1m)-17.21%
PT rev (3m)-13.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.26%
EPS NY rev (1m)-2.26%
EPS NY rev (3m)-9.66%
Revenue NQ rev (1m)-8.95%
Revenue NQ rev (3m)9.29%
Revenue NY rev (1m)8.94%
Revenue NY rev (3m)-15.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.25
P/FCF N/A
P/OCF N/A
P/B 2.62
P/tB 2.62
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)-1.39
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS0.23
BVpS2.8
TBVpS2.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -32.01%
ROE -38.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.82%
ROA(5y)-50.01%
ROE(3y)-68.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.87%
Cap/Sales 1.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.47
Quick Ratio 6.47
Altman-Z 4.39
F-Score3
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)22.42%
Cap/Depr(5y)19.09%
Cap/Sales(3y)1.18%
Cap/Sales(5y)8.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.47%
EPS Next Y-13.9%
EPS Next 2Y-6.23%
EPS Next 3Y-0.57%
EPS Next 5Y25.26%
Revenue 1Y (TTM)-60.55%
Revenue growth 3Y127.06%
Revenue growth 5Y16.3%
Sales Q2Q%-79.41%
Revenue Next Year-0.18%
Revenue Next 2Y36.14%
Revenue Next 3Y59.21%
Revenue Next 5Y71.03%
EBIT growth 1Y-94.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-21.79%
EBIT Next 3Y-15.88%
EBIT Next 5YN/A
FCF growth 1Y-23.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.15%
OCF growth 3YN/A
OCF growth 5YN/A

WAVE LIFE SCIENCES LTD / WVE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of WAVE LIFE SCIENCES LTD (WVE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to WVE.


What is the valuation status for WVE stock?

ChartMill assigns a valuation rating of 0 / 10 to WAVE LIFE SCIENCES LTD (WVE). This can be considered as Overvalued.


What is the profitability of WVE stock?

WAVE LIFE SCIENCES LTD (WVE) has a profitability rating of 1 / 10.


How financially healthy is WAVE LIFE SCIENCES LTD?

The financial health rating of WAVE LIFE SCIENCES LTD (WVE) is 8 / 10.